3626 results for «482»

Filter By

3626 results

CTO within a bifurcation

16 May 2024 – From EuroPCR 2024

This session will present various cases of chronic total occlusions (CTOs) within a bifurcation. Participants will learn about the challenges, diagnostic techniques, and treatment strategies for these complex cases, including the use of IVUS, CT angiography, and the hybrid algorithm for successful CTO interventions.

CTO within a bifurcation

ANOCA/INOCA: when angiography is not enough to reach a diagnosis

16 May 2024 – From EuroPCR 2024

This session provides practical knowledge on the diagnosis and management of patients with ANOCA/INOCA (Angina with Non-Obstructive Coronary Arteries/Ischemia with Non-Obstructive Coronary Arteries). It covers the evaluation of microvascular and vasomotor disorders in patients with non-obstructive coronary arteries, and the causes and management of patients with...

ANOCA/INOCA: when angiography is not enough to reach a diagnosis

PCR's Got Talent - Round 2 - Session 2

15 May 2024 – From EuroPCR 2024

This session features a selected abstract submission from EuroPCR 2024 on plaque characterization, outcomes, and predictors of recurrent events in stent failure, as studied using optical coherence tomography (OCT).

PCR's Got Talent - Round 2 - Session 2

PCR's Got Talent - Round 2 - Session 1

15 May 2024 – From EuroPCR 2024

PCR's Got Talent - Round 2 - Session 1

OPTIMUM: Outcomes of Percutaneous RevascularizaTIon for Management of SUrgically Ineligible Patients with Multivessel or Left Main Coronary Artery Disease

04 Nov 2021

Mirvat Alasnag reviews the OPTIMUM trial, presented by David E. Kandzari, which reports outcomes in a subset of patients who are increasingly seen in modern day catheterization laboratories. It is noteworthy that 1 in 5 patients with left main or multivessel disease are considered surgically ineligible.

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
OPTIMUM: Early Outcomes From a Prospective Registry of PCI in Patients at Prohibitive Risk for CABG

Primary and secondary outcomes of the Women's Ischemia Trial to reduce events in non-obstructive coronary artery disease (WARRIOR)

31 Mar 2025

Nicola Ryan provides her take on the WARRIOR trial which was presented by Eileen Handberg at ACC.25 in Chicago.

The manuscript for this trial has not been published and all assumptions are based upon the presentation.

Nicola Ryan

Author

Nicola Ryan
Primary and secondary outcomes of the Women's Ischemia Trial to reduce events in non-obstructive coronary artery disease
Didn’t find what you were looking for?